Rebecca Begley

Clinical targeting of HIV capsid protein with a long-acting small molecule

J. R. Somoza, W. Sundquist, Xiaohong Liu, 2020, Nature.

Downstream targets of let-60 Ras in Caenorhabditis elegans.

Stuart K. Kim, J. Lund, M. Kiraly, 2002, Developmental biology.

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

T. Wrin, J. Mellors, R. Begley, 2021, Science Translational Medicine.

Lack of Drug‐Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers

R. Begley, A. Mathias, B. Kearney, 2020, Clinical pharmacology in drug development.

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19

J. Dye, S. Pokhrel, R. Begley, 2022, Frontiers in Immunology.

PKC-{epsilon}-dependent survival signals in diabetic hearts.

R. Begley, L. Meggs, D. Mochly‐Rosen, 2005, American journal of physiology. Heart and circulatory physiology.

Biodistribution of intracellularly acting peptides conjugated reversibly to Tat.

R. Begley, D. Mochly‐Rosen, J. Baryza, 2004, Biochemical and biophysical research communications.

Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide.

R. Begley, D. Mochly‐Rosen, F. Ikeno, 2005, Circulation.